Causes and characteristics of death among HIV-1 infected patients with immunovirologic response to antiretroviral treatment

被引:12
|
作者
May, T [1 ]
Lewden, C
Bonnet, E
Heripret, L
Bevilacqua, S
Jougla, É
Costagliola, D
Morlat, P
Salmon, D
Chêne, G
机构
[1] Hop Brabois, Serv Malad Infect & Trop, F-54511 Vandoeuvre Les Nancy, France
[2] Univ Bordeaux 2, INSERM, U593, F-33076 Bordeaux, France
[3] Hop St Andre, Serv Med Interne & Malad Infect, Bordeaux, France
[4] Hop Archet, Serv Malad Infect & Trop, Nice, France
[5] INSERM, CepiDc, Le Vesinet, France
[6] INSERM, Paris, France
[7] Hop Cochin, Serv Med Interne Malad Infect & Trop, F-75674 Paris, France
来源
PRESSE MEDICALE | 2004年 / 33卷 / 21期
关键词
D O I
10.1016/S0755-4982(04)98968-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction To analyse the causes of death among HIV-infected adults in France in the year 2000. Methods Based on data from a national survey, our study describes and analyses the causes and characteristics of patients with immunological and virological response (CD4>200/mm(3), ARN-HIV<500 copies/mL), who died during antiretroviral treatment. Results Among a total of 964 deaths registered, data on 864 cases were available for analysis. One hundred forty-nine patients (17%) were immunovirological responders. The underlying causes of death were non AIDS-defining malignancies for 36 (24%), mainly due to lung cancer (16 cases), hepatocarcinoma (7) and ano-rectal carcinoma (3), AIDS for 22 (15%), mainly due to Non Hodgkin Lymphoma (10 cases) and uterine cancer (3), cardiovascular diseases for 22 (15%), post hepatitis C hepatic failure for 16 (11%), suicide for 16 (11%), and bacterial infections for 14 (9%). When comparing characteristics of death in the 149 responders versus the 715 other patients, the responders were significantly more frequently: coinfected by HCV+ (45 vs. 33%), injected drug addicts (40 vs. 27%), alcoholics (38 vs. 28%), and dyslipidemics (19 vs. 11%). In 2000, around 20% of registered deaths of HIV patients in France had occurred among good immunovirological responders. Conclusion To further reduce mortality among such efficiently treated patients, attention must be focused on treatable conditions such as hepatitis C, dyslipidemia and on the prevention of malignancies such as lung cancer and cervical or ano-rectal carcinoma.
引用
收藏
页码:1487 / 1492
页数:6
相关论文
共 50 条
  • [1] Antiretroviral treatment in HIV-1 infected pediatric patients: focus on efavirenz
    Larru, Beatriz
    Eby, Jessica
    Lowenthal, Elizabeth D.
    PEDIATRIC HEALTH MEDICINE AND THERAPEUTICS, 2014, 5 : 29 - 42
  • [2] Antiretroviral drug resistance among HIV-1 infected children failing treatment
    Mullen, J
    Leech, S
    O'Shea, S
    Chrystie, IL
    du Mont, G
    Ball, C
    Sharland, M
    Cottam, F
    Zuckerman, M
    Rice, P
    Easterbrook, P
    JOURNAL OF MEDICAL VIROLOGY, 2002, 68 (03) : 299 - 304
  • [3] Causes of Death in HIV-Infected Individuals with Immunovirologic Success in a National Prospective Survey
    Goehringer, Francois
    Bonnet, Fabrice
    Salmon, Dominique
    Cacoub, Patrice
    Paye, Aissatou
    Chene, Genevieve
    Morlat, Philippe
    May, Thierry
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2017, 33 (02) : 187 - 193
  • [4] Correlates of Adherence and Antiretroviral Treatment Failure in HIV-1 Infected Kenyan Patients
    Ochieng, Washingtone
    Kitawi, Rose C.
    Nzomo, Timothy J.
    Mwatelah, Ruth S.
    Hungu, Charity
    Kimulwo, Maureen J.
    Onyango, Kevin O.
    Lwembe, Raphael M.
    Mwamburi, Mkaya
    Ogutu, Berhnards R.
    Oloo, Florence A.
    Aman, Rashid
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2014, 30 : A166 - A166
  • [5] Selected genetic factors determine the antiretroviral treatment associated immune recovery among HIV-1 infected patients
    Aksak-Was, B.
    Urbanska, A.
    Leszczyszyn-Pynka, M.
    Parczewski, M.
    HIV MEDICINE, 2021, 22 : 68 - 68
  • [6] Prospective Antiretroviral Treatment of Asymptomatic, HIV-1 Infected Controllers
    Hatano, Hiroyu
    Yukl, Steven A.
    Ferre, April L.
    Graf, Erin H.
    Somsouk, Ma
    Sinclair, Elizabeth
    Abdel-Mohsen, Mohamed
    Liegler, Teri
    Harvill, Kara
    Hoh, Rebecca
    Palmer, Sarah
    Bacchetti, Peter
    Hunt, Peter W.
    Martin, Jeffrey N.
    McCune, Joseph M.
    Tracy, Russell P.
    Busch, Michael P.
    O'Doherty, Una
    Shacklett, Barbara L.
    Wong, Joseph K.
    Deeks, Steven G.
    PLOS PATHOGENS, 2013, 9 (10)
  • [7] HIV associated arthropathy and response to antiretroviral therapy in a HIV-1 infected child
    Shah, Ira
    JOURNAL OF PEDIATRIC INFECTIOUS DISEASES, 2006, 1 (01) : 53 - 55
  • [8] Hearing loss and antiretroviral therapy in patients infected with HIV-1
    Marra, CM
    Wechkin, HA
    Longstreth, WT
    Rees, TS
    Syapin, CL
    Gates, GA
    ARCHIVES OF NEUROLOGY, 1997, 54 (04) : 407 - 410
  • [9] Causes of Death and Risk Factors for Mortality among HIV-Infected Patients Receiving Antiretroviral Therapy in Korea
    Lee, Sun Hee
    Kim, Kye-Hyung
    Lee, Seung Geun
    Cho, Heerim
    Chen, Dong Hwan
    Chung, Joo Seop
    Kwak, Ihm Soo
    Cho, Goon Jae
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2013, 28 (07) : 990 - 997
  • [10] HLA - B 17 Prevalence in HIV-1 Infected Patients under Antiretroviral Treatment
    Shankarkumar, U.
    Shankarkumar, A.
    INTERNATIONAL JOURNAL OF HUMAN GENETICS, 2011, 11 (01) : 59 - 62